Dr. Santiago De Solo, MD
What this data tells you about Dr. De Solo
Dr. Santiago De Solo is a rheumatology specialist in Miami, FL, with 20 years of NPI registration. Based on federal Medicare data, Dr. De Solo performed 42,684 Medicare services across 2,604 unique beneficiaries.
Between the years covered by Open Payments, Dr. De Solo received a total of $106,044 from 55 pharmaceutical and/or device companies across 1290 individual payments. These payments are legal, publicly disclosed under the federal Sunshine Act, and common in rheumatology. The majority of payments are for speaking programs and promotional activities, reflecting participation in industry-sponsored events. Patients may wish to discuss these relationships with their provider.
The Data Coverage level for Dr. De Solo is Very High — reflecting how much public federal data is available about this provider. This is not a quality rating. Patients are encouraged to use this data as one of several factors when choosing a healthcare provider.
Florida License Status
FL DOH · MQA| Profession | License # | Status | Expires | Board Action |
|---|---|---|---|---|
| Medical Doctor | 59911 | Clear | January 31, 2028 | — |
Medicare Practice Summary
Medicare Utilization ↗Top procedures by volume
Ranked by number of services performed for Medicare patients. Avg. submitted charge is what the provider billed; avg. Medicare payment is what CMS paid.
| Procedure | Volume | Avg. paid | Avg. submitted |
|---|---|---|---|
| Denosumab injection (Prolia/Xgeva) | 20,042 | $18 | $42 |
| Romosozumab injection (Evenity) for osteoporosis | 9,255 | $8 | $18 |
| Abatacept infusion (Orencia) | 5,885 | $34 | $90 |
| Steroid injection (triamcinolone) | 2,224 | $1 | $4 |
| Hyaluronan or derivative, hymovis, for intra-articular injection, 1 mg | 1,824 | $13 | $114 |
| Office visit, established patient (20-29 min) | 882 | $69 | $158 |
| Office visit, established patient (30-39 min) | 371 | $98 | $233 |
| Aspiration and/or injection of fluid large joint using ultrasound guidance | 237 | $104 | $287 |
| Infusion into a vein for therapy, prevention, or diagnosis, 1 hour or less | 227 | $55 | $157 |
| Bone density scan (DEXA) | 192 | $40 | $137 |
| Drug injection, under skin or into muscle | 180 | $12 | $44 |
| Joint injection, major joint | 139 | $59 | $206 |
| Administration of chemotherapy into vein, 1 hour or less | 132 | $111 | $306 |
| Hyaluronan or derivative, orthovisc, for intra-articular injection, per dose | 118 | $100 | $270 |
| Injection into tendon at attachment to bone or muscle | 99 | $38 | $98 |
| Shoulder X-ray, 2+ views | 96 | $29 | $63 |
| X-ray of knee, 4 or more views | 89 | $38 | $85 |
| Injection of anesthetic agent and/or steroid into lower back and leg nerve (sciatic nerve) | 75 | $178 | $497 |
| New patient office visit (30-44 min) | 72 | $89 | $240 |
| X-ray of hand, minimum of 3 views | 60 | $31 | $69 |
| X-ray of lower and sacral spine, minimum of 4 views | 58 | $43 | $105 |
| Injection into tendon or ligament | 47 | $37 | $120 |
| Knee X-ray, 3 views | 43 | $31 | $77 |
| Office visit, established patient (10-19 min) | 40 | $48 | $95 |
| X-ray of upper spine, 6 or more views | 39 | $52 | $120 |
| Ultrasonic guidance for needle placement | 36 | $47 | $129 |
| X-ray of pelvis, 1-2 views | 33 | $23 | $69 |
| New patient office visit (45-59 min) | 33 | $126 | $364 |
| X-ray of both hips, 2 views | 27 | $34 | $80 |
| Foot X-ray, 3+ views | 25 | $27 | $63 |
| Hip X-ray, 2-3 views | 24 | $40 | $88 |
| Mri scan of leg joint without contrast | 22 | $104 | $507 |
| Mri scan of lower spinal canal without contrast | 19 | $103 | $480 |
| Telephone medical discussion with physician, 5-10 minutes | 15 | $18 | $30 |
| Mri scan of arm joint without contrast | 13 | $114 | $507 |
| Mri scan of upper spinal canal without contrast | 11 | $92 | $824 |
Industry Payment Transparency
Open Payments through 2024 ↗Payment profile
Industry payments classified by relationship type. Not all payments are equal — research and consulting reflect different relationships than speaking programs or meals.
Payment trend by year
Annual totals from pharmaceutical and medical device companies.
Payments by company (2024)
Associated products mentioned in payments ›
The majority of payments (84%) are for speaking programs and promotional activities, which reflect participation in industry-sponsored educational or marketing events. This is common in rheumatology and does not inherently indicate bias, but patients may wish to be aware. Total industry engagement is in the top 8% for rheumatology in FL.
Geographic Context
3.0 mi
Data Sources
| Provider Registry | ✓ NPPES | Weekly updates |
| Medicare Enrollment | ✓ PECOS | Monthly updates |
| Practice Data | ✓ Medicare Util. | Annual (CY lag) |
| Industry Payments | ✓ Open Payments | CY 2024 |
| Disciplinary History | — Not public | N/A |
This provider has data in 4 of 4 available federal datasets, with a Data Coverage level of Very High. This measures how much public data is available about a provider — not how good they are. How we calculate this →
Summary
Dr. De Solo is a mixed practice specialist, with moderate Medicare volume, with speaking/promotional industry engagement in the top 8% of FL peers, with 20 years of NPI registration.
This summary is auto-generated from federal data. It describes data availability and patterns — not clinical quality. Read our methodology →
Frequently Asked Questions
Is Dr. De Solo experienced with denosumab injection (prolia/xgeva)?
Does Dr. De Solo receive payments from pharmaceutical companies?
How do Dr. De Solo's costs compare to other rheumatologists in Miami?
What does Data Coverage mean?
Is this data up to date?
Explore related providers
All data on this page is sourced verbatim from public federal records published by the U.S. Centers for Medicare & Medicaid Services (CMS): NPPES ↗, Open Payments ↗, Medicare Provider Utilization ↗, and PECOS. Publication is mandated by the Physician Payments Sunshine Act (§6002 ACA, 42 U.S.C. §1320a-7h) and the Freedom of Information Act.
This page is not medical advice, an endorsement, a recommendation, or a quality rating. The Transparency Score measures data completeness — how much federal information exists for this provider — not clinical performance, patient outcomes, or quality of care. Always verify information directly with the provider and consult a licensed clinician before making medical decisions.
Provider corrections: Provider portal · Privacy questions: Privacy Policy · Terms: Terms of Use · Methodology: Methodology